Trade Mark Journal No.2025/039 26 September 2025

UK00004252738 21 August 2025 (5,42)

XENA

Class 5: Pharmaceutical drugs; Pharmaceutical preparations for use in oncology; Pharmaceutical preparations; Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for use in hematology; Cardiovascular pharmaceutical preparations; Pharmaceutical products for the treatment of cancer; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations and substances for the treatment of cancer; Cardiovascular pharmaceuticals; Pharmaceutical preparations for the treatment of cancer; Drug delivery agents; Anti-cancer drugs; Antitumor drugs; Drug delivery agents that facilitate the delivery of pharmaceutical preparations; Pharmaceutical preparations and substances for the prevention of cancer; Pharmaceutical preparations for the treatment of cardiovascular disease ; Compounds for treating cancer; Biological preparations for the treatment of cancer; Pharmaceutical preparations for treating malignant tumors; Medicines for the treatment of cardiovascular and cerebrovascular diseases; Tumour antigens; Pharmaceutical preparations for the treatment of tumours; Pharmaceutical preparations for the prevention of tumours; Pharmaceutical preparations for the prevention of autoimmune diseases; Pharmaceutical preparations for the treatment of autoimmune disorders; Chemotherapeutics; Pharmaceutical preparations for the prevention of inflammatory diseases; Pharmaceutical preparations for the prevention of autoimmune disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for treating respiratory diseases; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for the prevention of diseases caused by bacteria; Tumor suppressing agents; Pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for the prevention of diseases of the immune system.
Class 42: Development of pharmaceutical preparations and medicines; Pharmaceutical research services; Research and development for the pharmaceutical industry; Research of pharmaceuticals; Research and development in the pharmaceutical and biotechnology fields; Drug discovery services; Scientific research for medical purposes in the area of cancerous diseases.

Xterna Ltd